HEPATX
HepaTx is developing regenerative medicine solutions to address the need for better therapies for life-threatening liver diseases. The technology invented at Stanford University enables efficient hepatocyte production for therapeutic purposes. Its therapeutics can replace lost liver function to treat those with end-stage of liver disease, potentially saving the cost and morbidity of whole organ transplant.
HEPATX
Industry:
Biotechnology Medical Therapeutics
Founded:
2015-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.hepatx.com
Total Employee:
1+
Status:
Active
Total Funding:
2.1 M USD
Technology used in webpage:
Google Apps For Business Squarespace Hosted
Current Employees Featured
Founder
Investors List
Bioverge
Bioverge investment in Seed Round - HepaTx
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - HepaTx
Asymmetry Ventures
Asymmetry Ventures investment in Seed Round - HepaTx
SP Investment Fund
SP Investment Fund investment in Seed Round - HepaTx
StartX (Stanford-StartX Fund)
StartX (Stanford-StartX Fund) investment in Seed Round - HepaTx
Grey Sky Venture Partners
Grey Sky Venture Partners investment in Seed Round - HepaTx
Y Combinator
Y Combinator investment in Seed Round - HepaTx
Nahkoda Capital
Nahkoda Capital investment in Seed Round - HepaTx
Newest Events participated
Official Site Inspections
http://www.hepatx.com Semrush global rank: 5.9 M Semrush visits lastest month: 1.4 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "HepaTx"
HepaTx
Using regenerative medicine technologies, HepaTx is developing new types of treatments, based on stem cells, to bring new therapies to patients with late stage liver disease, as an alternative …See details»
About HepaTx — HepaTx
The HepaTx pipeline spans initial niche indications with lower developmental costs, rapid regulatory approval paths and large market chronic liver disease indications. A1ATD: Alpha 1 anti-trypsin deficiency PKU: Phenylketonuria …See details»
HepaTx - Crunchbase Company Profile & Funding
Organization. HepaTx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Hepatx is developing regenerative medicine …See details»
HepaTx Corporation - LinkedIn
HepaTx Corporation | 723 followers on LinkedIn. Off-the-shelf cell therapies for liver disease | Our vision is to provide regenerative medicine treatments that free patients from chronic liver ...See details»
Hepatx Corp. - Drug pipelines, Patents, Clinical trials - Synapse
HepaTx’s approach to developing an off-the-shelf cell therapy to treat patients with serious liver disease is unique in that HepaTx does not genetically modify its cells, it uses adipose tissue as …See details»
HepaTx Company Profile 2024: Valuation, Funding & Investors
HepaTx General Information Description. Developer of a stem cell-based therapy designed to replace liver transplants as a treatment for liver failure. The company's therapies are based on …See details»
HepaTX - Products, Competitors, Financials, Employees, …
HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials. Sep 10, 2024. News provided by Share this article Share toX PALO …See details»
HepaTx Enters Collaboration with Mayo Clinic to …
Sep 10, 2024 HepaTx, a biotechnology company specializing in regenerative medicine, has entered into a license agreement with Mayo Clinic to advance HepaTx's innovative stem cell technology into clinical trials.See details»
Hepatx Corporation - VentureRadar
" HepaTx is a biotechnology company focused on developing off-the-shelf cell therapies for liver disease. Utilizing regenerative medicine technologies, the firm creates stem-cell-based …See details»
Salah Kivlighn, Ph.D. , CEO, HepaTx Corporation, A …
About Salah Kivlighn and HepaTx Corporation: My colleagues describe me as an inspiring results-driven leader with a rare blend of science and business acumen across several therapeutic classes, including oncology, autoimmunity and …See details»
Intro — HepaTx
ABOUT HEPATX. STRATEGY TEAM CAREERS SCIENCE MEDIA CONTACT US Intro . Off-the-shelf cell therapies for liver disease. HepaTx Awarded 2022 Impact Company of The Year …See details»
hepatx.com Reviews: Is this site a scam or legit?
Hepatx.com Review. The Scam Detector website Validator gives hepatx.com a medium-risk trust score on the platform: 65.6.It signals that the business is best defined by the following tags: …See details»
HepaTx announces issuance of patent entitled "Methods and …
Mar 28, 2022 HepaTx is a cell therapy and regenerative medicine company developing new types of stem cell-based treatments for patients with late-stage liver disease, a highly …See details»
HepaTx Enters Collaboration with Mayo Clinic to Advance Cell …
Sep 10, 2024 I can think of no better organization to work with given their outstanding liver disease and regenerative ... HepaTx is a cell therapy and regenerative medicine company …See details»
HepaTx Secures Canadian Patent for Cutting-Edge ... - BioSpace
Sep 26, 2023 The new Canadian patent represents a significant step towards realizing these goals and marks another chapter in HepaTx’s journey of innovation and excellence. About …See details»
HepaTx Enters Collaboration with Mayo Clinic to Advance Cell …
Sep 10, 2024 I can think of no better organization to work with given their outstanding liver disease and regenerative medicine expertise,” commented Eric Schuur, the CEO of HepaTx. …See details»
MEET THE TEAM - HepaTx
Dr. Avnesh S Thakor Scientific Advisor. Dr Thakor is an adult and pediatric-certified Interventional Radiologist whose vision and research are focused on developing the area of "Precision …See details»
HepaTx enters collaboration with Mayo Clinic to advance cell …
Catalyzing innovation to shape the future of healthcare for the benefit of patients.See details»
SCIENCE — HepaTx
Until now, organ transplant has been the one and only efficacious therapy to save hundreds of vital functions for thousands of lives. It is a successful procedure, but its availability is …See details»
HepaTx Enters Collaboration with Mayo Clinic to Advance Cell …
Sep 10, 2024 I can think of no better organization to work with given their outstanding liver disease and ... HepaTx is a cell therapy and regenerative medicine company developing cell …See details»